Scott, L V, Burnett, F, Medbak, S et al. · Psychological medicine · 1998 · DOI
This study looked at whether an opioid-blocking drug called naloxone could trigger the body's stress hormone system in ME/CFS patients versus healthy people. The researchers found that when given naloxone, ME/CFS patients had a blunted response in one stress hormone (ACTH) compared to healthy controls, suggesting that excess opioids are not the primary cause of the stress hormone problems seen in ME/CFS.
Understanding the mechanisms behind abnormal stress hormone function in ME/CFS is crucial for developing targeted treatments. This study helps rule out one proposed explanation (excessive opioid inhibition), narrowing the focus for future research into what actually causes the HPA dysregulation that affects many ME/CFS patients.
This study does not prove what the actual mechanism of HPA dysregulation in ME/CFS is—only that excessive opioid inhibition is unlikely to be the primary cause. The small sample size (13 per group) limits generalizability. The single-timepoint measurement of hormone response may not capture all aspects of HPA dysfunction in ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.